Entry Detail



General Information

Database ID:exR0012368
RNA Name:RPLP0
RNA Type:mRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):120196699End Site(bp):120201235
External Links:ENSG00000089157



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC092718.3
chr16
81053587
81096296
-
AC007192.1
chr19
18153158
18178117
+
AC091167.2
chr15
90249556
90272208
+
AC138811.2
chr16
18788063
18801519
-
ACTR3
chr2
113890063
113962596
+
ADGRA3
chr4
22345071
22516066
-
ACTR5
chr20
38748460
38772520
+
AL121594.1
chr14
35122549
35317474
+
AGPAT5
chr8
6708642
6761503
+
AARS2
chr6
44298731
44313347
-
AGPAT3
chr21
43865223
43987592
+
AL132671.2
chr6
117318211
117573571
-
AC010422.3
chr19
12643831
12648397
-
AL022238.4
chr22
40346529
40410054
+
AK3
chr9
4709556
4742043
-
ADNP
chr20
50888916
50931437
-
AC010323.1
chr19
8308283
8321379
-
ABCF1
chr6
30571393
30597179
+
AHCYL1
chr1
109984765
110023742
+
AC011455.2
chr19
38915404
38949855
-
AL136295.1
chr14
24189157
24213473
-
AC011511.1
chr19
10305427
10316009
-
AC006064.6
chr12
6556886
6607367
-
AC005832.4
chr12
4604944
4662643
+
ACTG1
chr17
81509971
81523847
-
AC010463.1
chr19
17267418
17282966
+
AL133352.1
chr10
100505628
100529881
-
AKT1
chr14
104769349
104795751
-
AL928654.3
chr14
105487199
105492267
+
ACAT1
chr11
108116695
108147603
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3609
chr7
98881700
98881723
+
hsa-miR-4426
chr1
192716333
192716349
+
hsa-miR-6833-3p
chr6
32179856
32179876
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002470.2
chr22
20979462
20998121
+
AC007952.4
chr17
19112000
19112636
-
AC008937.3
chr5
56927874
56929573
+
AC010542.4
chr16
66549280
66551189
+
AC010642.2
chr19
58309727
58327248
-
AC010655.2
chr7
128455937
128469197
+
AC010655.4
chr7
128455840
128493859
+
AC010733.2
chr2
60925909
60931610
+
AC020910.5
chr19
34733298
34733837
-
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC064802.1
chr8
114282067
114295839
+
AC068768.1
chr12
123262060
123262402
+
AC073896.4
chr12
56162359
56190284
-
AC104109.4
chr5
134205614
134371044
-
AC105036.3
chr15
75527150
75601205
-
AC109460.3
chr16
28974804
28990775
+
AC147651.4
chr7
603185
608482
+
AD000090.1
chr19
35557956
35581954
+
ADD3-AS1
chr10
109940104
110008381
-
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.